Hyperlipidemia-Induced MicroRNA-155-5p Improves β-Cell Function by Targeting Mafb

Area of Science:

• Endocrinology
• Molecular Biology
• Metabolic Research

Background:

• High-fat diets elevate bacterial lipopolysaccharide (LPS), stimulating GLP-1-mediated insulin secretion via IL-6.
• MicroRNA-155-5p (miR-155-5p) increases IL-6 and is upregulated by LPS and hyperlipidemia.
• The role of miR-155-5p in islet stress response to hyperlipidemia remains unclear.

Purpose of the Study:

• To investigate the role of miR-155-5p in the pancreatic beta-cell stress response to hyperlipidemia.
• To elucidate the mechanism by which miR-155-5p influences glucose metabolism and insulin resistance.

Main Methods:

• Studied miR-155-5p expression in murine pancreatic beta-cells under hyperlipidemic conditions.
• Utilized Mir155 knockout mice to assess the impact of miR-155-5p deficiency.
• Investigated the downstream targets and signaling pathways affected by miR-155-5p.

Main Results:

• Hyperlipidemia-associated endotoxemia upregulates miR-155-5p in murine pancreatic beta-cells.
• Upregulation of miR-155-5p improved glucose metabolism and beta-cell adaptation to obesity-induced insulin resistance.
• miR-155-5p exerts its effects by suppressing v-maf musculoaponeurotic fibrosarcoma oncogene family, protein B, promoting IL-6-induced GLP-1 production.
• Mir155 knockout mice showed reduced GLP-1 levels, increased obesity, dyslipidemia, and atherosclerosis.

Conclusions:

• Induction of miR-155-5p in beta-cells by hyperlipidemia-associated endotoxemia is a protective mechanism.
• miR-155-5p enhances beta-cell adaptation to insulin resistance, improving glucose homeostasis.
• Dysregulation of miR-155-5p contributes to metabolic dysfunction in hyperlipidemia.